Terrence William Pizzie
Vorstandsvorsitzender bei Astrea Bioseparations Ltd.
Aktive Positionen von Terrence William Pizzie
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Vorstandsvorsitzender | 14.06.2021 | - |
Karriereverlauf von Terrence William Pizzie
Ehemalige bekannte Positionen von Terrence William Pizzie
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Genetix Group Ltd. provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis. The company operates research, pharmaceutical and biotherapeutic developments. Its product brands include ClonePix, Clone Pix FL, Clone Select Imager, Clone Fill, Cell Dispense, QP Expression, QP Display, QP Interactor, OP Evolution, Q Select, O Pix2 XT, O Pix2, MegaPix, QBot, gelPix, gloPix, Q ArrayMini, Q Array2, Q ArrayMax, aliQuot, Q Fill and Mega Pix. Genetix was founded by Mark Reid in 1991 and is headquartered in New Milton, the United Kingdom. | Direktor/Vorstandsmitglied | - | 14.01.2010 |
Corporate Officer/Principal | 01.09.2007 | 14.01.2010 | |
Pacific Biosciences UK Ltd. | Vertrieb & Marketing | - | - |
Biacore AB | Corporate Officer/Principal | 01.01.2005 | - |
Applied Biosystems Ltd. | Corporate Officer/Principal | 01.01.1988 | - |
HORIZON DISCOVERY GROUP PLC | Direktor/Vorstandsmitglied | 08.05.2018 | - |
Vorstandsvorsitzender | 08.05.2018 | - | |
Corporate Officer/Principal | 01.02.2017 | 08.05.2018 |
Ausbildung von Terrence William Pizzie
The University of Reading | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Schweden | 2 |
Operativ
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Genetix Group Ltd. provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis. The company operates research, pharmaceutical and biotherapeutic developments. Its product brands include ClonePix, Clone Pix FL, Clone Select Imager, Clone Fill, Cell Dispense, QP Expression, QP Display, QP Interactor, OP Evolution, Q Select, O Pix2 XT, O Pix2, MegaPix, QBot, gelPix, gloPix, Q ArrayMini, Q Array2, Q ArrayMax, aliQuot, Q Fill and Mega Pix. Genetix was founded by Mark Reid in 1991 and is headquartered in New Milton, the United Kingdom. | Health Technology |
Horizon Discovery Group Ltd.
Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Applied Biosystems Ltd. | |
Biacore AB | |
Pacific Biosciences UK Ltd. | |
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Terrence William Pizzie
- Erfahrung